InvivoGen offers a collection of inhibitors suited for the study of innate immunity signaling pathways.
Modulators of various actors implicated in pattern-recognition receptor (PRR) and inflammasome signaling, as well as autophagy pathways.
Additionally, we provide a set of small molecule inhibitors acting at different stages of the SARS-CoV-2 infection to support COVID-19 research, and prodrugs acting as DNA synthesis inhibitors to achieve cell selection using suicide genes.
